Navigation Links
Face Masks Fly Off Shelves in Preparation for Flu Season
Date:9/23/2009

MOORESVILLE, N.C., Sept. 23 /PRNewswire/ -- Nukepills.com today announced the replenishment of its stock of N95 Particulate Masks just in time for the upcoming flu season. A deluge of online orders in May of this year, in response to media stories of the Swine Flu Virus (H1N1), depleted the company's large inventory in just a few days.

"We had run out of stock of N95 face masks back in May. We were surprised by the rush of orders that literally happened overnight," said Troy Jones, president of Nukepills.com. "We have just now received a huge shipment of fresh N95 face masks to cover our wholesale and retail business for the remainder of the flu season. Aside from frequent hand washing, the Centers for Disease Control and Prevention (CDC) is recommending the use of certain types of face masks if you are in close contact with someone who has, or may have, the swine flu. We only stock N95 masks that are both NIOSH and FDA approved. Anything less would not give our customers the protection they demand."

N95 face masks available from Nukepills.com are individually sealed to maintain freshness and integrity of the product and fold flat for easy storage and portability. They are also approved by the FDA for use as surgical masks.

Nukepills.com, celebrating its 10th year in business, is an Internet-based supplier of, primarily, radiation emergency products that protect against dirty bomb radiation, nuclear reactor accidents and nuclear weapon fallout, and are used for radiation therapy/decontamination in hospitals. The company was founded in 1999 as a means of supplying FDA approved Iosat Potassium Iodide directly to the general public and now has international sales programs throughout Canada, Europe, Asia and the Middle East. In early 2009, Nukepills.com sold 5.4 million doses of FDA approved ThyroShield(TM) Liquid Potassium Iodide to Kuwait's Ministry of Health and expects Government Emergency Preparedness grants and civilian orders to continue to drive sales of all products well into 2010.

    Contact:

    Troy Jones, President
    Nukepills.com
    Ph: 866-283-3986
    info@nukepills.com
    631 Brawley School Rd STE 407
    Mooresville, NC 28117
   http://www.nukepills.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Nukepills.com
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Anthera Enters Into Manufacturing Agreements for Varespladib in Preparation for Pivotal Phase III Trials
2. CoreSpine Technologies Expands Spinal Disc Site Preparation Efforts
3. Seriously Low Vaccination Rates Cause Experts to Call for Increased Immunization Before Influenza Season Peaks
4. Flu Season Is Here -- Vaccinations Are Still Plentiful
5. Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine
6. Childhood Influenza Immunization Coalition Encourages Vaccination Throughout the Influenza Season
7. Concentra Medical Centers Gears Up for Flu Season to Keep Area Workforce Healthy
8. Olympic Gold Medalist Kristi Yamaguchi Joins American Lung Association of Michigan to Address Seriously Low Vaccination Rates; Urge Metro-Detroiters to Get Immunized This Season
9. Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program
10. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
11. Mosquito Season Approaching: American Heartworm Society Reminds Pet Owners of Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/5/2017)... The Cincinnati location of ... (NYSE: DPLO), has been awarded a Top Workplaces 2017 ... Results are based on an employee survey administered by WorkplaceDynamics, ... improvement. The survey measures several aspects of workplace culture, including ... ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
(Date:6/1/2017)... 2017 Nutriceutical Holdings (NH), parent company of ... and KD Pharma Group have decided to join forces ... Pharma Group. KD Pharma Group will become the largest ... the entire company. "We believe we have ... to growing the NH companies by providing us with ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... 23, 2017 , ... Ulster University, Magee Campus in Northern Ireland is hosting ... pm to present to graduate students exciting new and innovative hope research based on ... by The Health Improvement Service of the Western Health & Social Care Trust (WHSCT) ...
(Date:6/23/2017)... ... June 23, 2017 , ... Jusino Insurance Services, ... communities in the greater Chicago metropolitan area, is embarking on a charity drive ... in Chicago. , Founded in 1897, Hephzibah Children’s Association is one of the ...
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & ... to families and business owners in North Central West Virginia, is embarking on ... to differently abled residents in the region. , The Stepping Stones organization offers ...
(Date:6/22/2017)... , ... June 22, 2017 , ... Branches, Inc. has ... than $245,000 in grant funding to support its programs focused on providing opportunity to ... was awarded a grant by the Foundation of $15,000 to support its , Climb ...
(Date:6/22/2017)... ... 2017 , ... United Benefit Advisors (UBA), the nation’s leading ... its newest Partner Firm. Headquartered in Coconut Creek, Florida, Whipple & Company was ... benefit packages that strengthen the relationship between employer and employee. , “We are ...
Breaking Medicine News(10 mins):